PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on ...

Keros Therapeutics, Inc. ("Keros” or the "Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of ...

There are no assurances that a transaction will be undertaken as a result of this strategic review process. It is Willow's current intention not to disclose developments with respect to the ...

Pasofino is issuing this cleansing press release to disclose material information related to the strategic review process in order to allow Pasofino to undertake a financing to secure funds ...

Getty Copper Inc. (the " Company ") (TSXV: GTC) announces that it has initiated a strategic review process to evaluate a range of alternatives to advance its mineral properties and enhance shareholder ...

Additionally, the current strategic review process being led by a special committee of the board is already attracting "significant" interest. The strategic review process includes analysis and ...

The grocer sold a 7% shareholding in Carmila for $194.5 million as part of a strategic review of its portfolio.

“During the pendency of the strategic review process, we remain focused on the execution of our strategy.” There can be no assurance that this process will result in the Company pursuing a ...

You have permission to edit this article. Edit Close Activate Subscribe My Account Logout Login/Register ...

is announcing that the board of directors ("the Board") has formed a special committee of independent directors to lead a comprehensive strategic review process to consider opportunities to ...